Specialities

Specialities

Bladder Cancer
Breast Cancer
Colorectal Cancer
COVID-19
Dermatological Cancers
Diagnostics and Screening
Gastrointestinal Cancers
Genitourinary Cancer
Gynaecological Cancers
Haematological Malignancies
Haematology
Head and Neck Cancer
Immunotherapy
Leukaemia
Lung Cancer
Lymphoma
Multiple Myeloma
Endocrine Cancers
Ovarian Cancer
Pancreatic Cancer
Paediatric Oncology
Policy
Prostate Cancer
Renal Cancer
Sarcoma
Supportive Cancer Care
Soft Tissue Tumours
Rare Disease Day
Neuro-oncology
Pathology
Radiology
Radiotherapy
Rare Diseases
Search

Trending Topic
3 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Foreword – touchREVIEWS in Oncology & Haematology, Volume 21, Issue 1, 2025

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin
Gastrointestinal Cancers
4 mins

Dr Yuri Yoshinami: Shaping the future of cancer treatment: touchONCOLOGY Future Leaders 2025

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 6th 2025

“By engaging in research early, young oncologists can contribute to scientific discovery”

Q1. What inspired you to pursue a career in oncology?

Initially, as a gastroenterologist, I experienced many benign diseases and endoscopic procedures, but oncology was what interested me the most. With the present medical treatment, unresectable and recurrent cancers cannot be cured. However, it is certain that many drugs have been developed and the prognosis has been improved. Cancer research is linked to a wide range of fields including molecular biology, immunology and genomics, and there are always new discoveries and technologies that continue to evolve, making it a continuous challenge. Furthermore, as patients and their families face difficult situations, I was very attracted to the role of physicians who can provide not only medical strength but also psychological and social support. I also decided to pursue oncology because of my desire to shape the future of treatment through personalized medicine amidst the advancement of cutting-edge technologies such as next-generation sequencing.

 

Q2. What is the most valuable lesson a mentor has shared with you, and how has it influenced your work?

My mentor gave me lessons that have had a profound impact on my work attitude and outlook on life. Two of them stand out in my mind. One is the advice to “see the whole patient, not just numbers and data”. These words taught me the importance of understanding and respecting the patient’s life background and values. I always keep in mind in my clinical practice the idea that no matter how advanced the treatment may be, true care cannot be established if the patient’s own wishes and the wishes of the family are ignored. The other is to “have an opinion that is backed up by science”. Oncology is constantly being updated. As a physician, I believe that it is important and in the best interest of the patient to be able to sift through this vast amount of information and understand its accurate content before treating the patient. I feel that by valuing these lessons learned, we are better able to promote better treatment and care.

 

Q3. How can aspiring oncologists make a meaningful impact early in their careers?

For young oncologists to make a meaningful impact in the early stages of their careers, it is important to be aware of several key points. First, active participation in research is important. By getting involved in ongoing projects at research institutions and engaging in research, we can contribute to scientific discovery from an early stage. Also, do not forget to build trusting relationships with your patients. When interacting with patients as a resident, showing empathy and providing quality care to each patient will have a profound impact not only on the patient’s experience of care, but also on our own development as a physician. Additionally, active participation in the community is important. We can expand our national and international network by visiting conferences and meetings and learning the latest information and techniques while disseminating your ideas and findings. And there are ways to contribute in the field of education as well. By learning and teaching younger students, we can deepen our own understanding and, at the same time, influence those around us. Through these efforts, we can make a meaningful contribution to the field of oncology even in the early stages of our careers.

 

Yuri Yoshinami is a resident in the Department of Gastrointestinal Medical Oncology at the National Cancer Center Hospital in Japan. After graduating from university, she practiced gastroenterology, including benign diseases, but decided to specialize in oncology and has been working in this department since 2022. Her specialty is chemotherapy for gastrointestinal cancers, and she is studying the relationship between immune checkpoint inhibitors (ICIs) and the intestinal microbiota. She is currently conducting a prospective study of antibiotic fecal microbiota transplantation in patients with unresectable or recurrent esophageal or gastric cancer who are scheduled to receive ICIs(Biorich2 trial).

Disclosures: Yuri Yoshinami has no financial or non-financial conflicts of interest to declare in relation to this article. 

Cite: Dr Yuri Yoshinami: Shaping the future of cancer treatment: touchONCOLOGY Future Leaders 2025. touchONCOLOGY. February 6th, 2025

Opening soon!

We are excited to announce that nominations for the touchONCOLOGY Future Leaders 2026 will open soon, and we invite the oncology and haematology community to share their suggestions for exceptional individuals who are shaping the future of oncology and haematology through innovation and excellence in patient care.

Nominations for touchONCOLOGY Future Leaders 2026

Register below to hear about nominations as soon as they open!

SIGN UP to touchONCOLOGY!

Join our global community today for access to thousands of peer-reviewed articles, expert insights, and learn-on-the-go education across 150+ specialties, plus concise email updates and newsletters so you never miss out.

Click here to REGISTER NOW >>>

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Foreword – touchREVIEWS in Oncology & Haematology, Volume 21, Issue 1, 2025

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Advertisement

    • Related Content in Gastrointestinal Cancers

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup